DRKS00021517招募中不适用
German Registry for Marginal Zone Lymphoma and Follicular Lymphoma
niversitätsklinikum Ulm0 个研究点目标入组 1,500 人开始时间: 2020年5月5日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 1,500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 99 Years（—）
- 性别
- All
入选标准
- •Confirmation of histological diagnosis of MZoL and FL by a reference pathologist.
- •Consent form signed by the patient.
排除标准
- •Lack of consent.
- •Lack of legal capacity or insight.
- •Inclusion of active therapy of FL in a clinical trial.
研究者
相似试验
招募中
不适用
German Lymphoma Alliance registryC83.3Diffuse large B-cell lymphomaDRKS00033272German Lymphoma Alliance (GLA) e.V.10,000
招募中
不适用
German national T-Cell Lymphoma Registry and Biobank of the German Lymphoma Alliance (GLA) and Ostdeutsche Studiengruppe für Hämatologie und Onkologie (OSHO)C86C84Other specified types of T/NK-cell lymphomaMature T/NK-cell lymphomasDRKS00030561Martin-Luther-Universität Halle-WittenbergUniversitätsklinikum Halle (Saale)600
招募中
不适用
Registry of the European Mantle Cell Lymphoma NetworkMantle cell lymphomaORPHA:52416C83.1DRKS00032670niversitätsmedizin der Johannes Gutenberg-Universität Mainz100,000
尚未招募
不适用
German Lupus RegistryM32Systemic lupus erythematosusDRKS00032997niversitätsklinikum Köln - Klinik II für Innere Medizin500
进行中（未招募）
1 期
Efficacy of pembrolizumab in patients with marginal zone lymphomaMarginal Zone LymphomaMedDRA version: 20.0Level: PTClassification code 10076596Term: Marginal zone lymphomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2018-000187-28-DEniversity Hospital Ulm56